[250 Pages Report] Newly released Spatial Mass Spectrometry Market analysis report by Future Market Insights shows that global sales of Spatial Mass Spectrometry Market in 2021 was held at US$ 224.1 Million. With 15.3%, the projected market growth during 2022 to 2032 is expected to be significantly higher than the historical growth.
Spatial Transcriptomics is expected to be the highest revenue generating technology, projected to grow at a CAGR of over 16.6% during 2022 to 2032.
| Attributes | Details |
|---|---|
| Global Spatial Mass Spectrometry Market CAGR (2022 to 2032) | 15.3% |
| Global Spatial Mass Spectrometry Market Size (2022) | US$ 254.8 Million |
| Global Spatial Mass Spectrometry Market Size (2032) | US$ 1 Billion |
| USA Spatial Mass Spectrometry Market CAGR (2022 to 2032) | 14.8% |
| Key Companies Covered | 10x Genomics; Dovetail Genomics; S2 Genomics Inc; NanoString Technologies Inc; Seven Bridges Genomics; PerkinElmer, Inc.; Bio-Techne; Danaher Corporation; IonPath, Inc. |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Spatial Mass Spectrometry Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value of the Spatial Mass Spectrometry Market increased at around 12.7% CAGR.
The factors pushing the Spatial Mass Spectrometry Market growth include the growing cancer prevalence and incidence rates. Geographical omics combines molecular analysis with geographical data on the location of a cell within a tissue.
Omics is a broad term that includes epigenomics, genomics, transcriptomics, lipidomics, proteomics, and metabolomics, among other studies. One of the key incentives for Spatial Mass Spectrometry is its high potential as diagnostic tools, notably in oncology.
The market's modest acceleration is attributable to technological advancements in Spatial Mass Spectrometry combined with aggressive spatial penetration expansion. Geographical analysis provides for improved molecular research regarding spatial information.
New Spatial Mass Spectrometry solutions and products are continually being developed by startups, established players, and expanding enterprises in the market. They're also participating in mergers and acquisitions, which is hastening the implementation of Spatial Mass Spectrometry around the world.
Companies are employing Spatial Mass Spectrometry to better comprehend molecules during clinical trial investigations. The usage of Spatial Mass Spectrometry in pharmaceutical research and discovery phases promotes substantial growth in the Spatial Mass Spectrometry market.
The rising adoption of spatial genomics and transcriptomics approaches for drug discovery and development, as well as increased R&D investments and public-private funding, are some of the primary drivers of the spatial genomics and transcriptomics market. In addition, the advent of technologically improved devices for spatial genomics analysis is fueling market expansion.
The market for spatial genomics and transcriptomics will grow fast as the potential of spatial genomic analysis with the growth in cancer diagnosis tools, and the arrival of the fourth generation of sequencing. Genome positioning is an intriguing novel biomarker that is required in a range of cancer types.
For a range of medical conditions, spatial patterns in the genome have been uncovered, leading to the use of spatial information as a diagnostic biomarker for a variety of diseases. Biomarkers are in high demand because they make it easier to distinguish between benign and malignant tumours. As a result, there is a growing demand for spatial genomics analysis as a cancer detection tool.
A variety of spatial transcriptomics techniques have been developed and successfully implemented to fulfil the growing demand for a deeper understanding of tissue profiling.
Principal Consultant
The use of Spatial Omics in drug discovery and development is becoming more common. During clinical trial investigations, companies are using Spatial Mass Spectrometry to better understand molecules. The use of Spatial Mass Spectrometry in medication development and discovery phases supports huge growth in the Spatial Mass Spectrometry market today and in the near future.
The market for Spatial Mass Spectrometry will expand owing to the upcoming Spatial Mass Spectrometry technologies and improvements. For example, Spatial Transcriptomics, for example, is an in situ capture technology that allows for the quantification and visualization of transcriptomes in particular tissue slices.
The use of Spatial Mass Spectrometry techniques in cancer diagnostics is expected to yield significant results in the near future.
North America leads the Spatial Mass Spectrometry market, owing to the development of technology to discover illness biomarkers. The market is growing due to rising demand for cancer treatment and the occurrence of cancer in North America, where around 1.2 Mn women get biopsies each year.
And about 20% of them have been told they have breast cancer. Furthermore, the market's expansion would be aided by the availability of qualified experts and healthcare facilities equipped with cutting-edge diagnostic procedures and medicines throughout the projection period.
In the Spatial Mass Spectrometry market, Asia Pacific held a sizable proportion of the global market. Factors contributing to the region's growth include an increase in the number of enterprises entering the market, as well as biological activities and research studies, all of which are expected to promote the use of Spatial Mass Spectrometry tools throughout the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The United States is expected to have the highest market share of US$ 378.4 Mn by the end of 2032. In 2021, the United States had the highest revenue share of over 35%. The market is expanding as the prevalence of chronic diseases including cancer and heart disease rises. Cancer is one of the leading causes of death in the United States. In 2018, around 1,735,350 new cancer diagnoses and 609,640 cancer-related deaths were recorded.
The Spatial Transcriptomics segment is forecasted to grow at the highest CAGR of over 16.6% during 2022-2032. This segment's growth is fuelled by the introduction of novel tools and instruments. Through this procedure, the technology may aid in the discovery of the subcellular localization of mRNA molecules.
Furthermore, the technology makes the process of studying genomic analysis much easier. This could potentially meet the needs of biological specimens of nucleic acid or single cells. Market growth is expected to be aided by these factors.
These techniques generally promote fields in molecular genetics and biochemistry associated with structure-oriented fields such as embryology and histology. This allows the genomics segment to grow at a faster rate than the rest of the market over the forecasted timeframe.
The FFPE segment is forecasted to grow at the highest CAGR of over 15.8% during 2022-2032. The FFPE sector has the largest market share of around 55% due to breakthroughs in the examination, experimental research, and diagnostic progress. Furthermore, the fresh frozen segment is predicted to grow at the fastest rate due to increased demand.
Among the leading Spatial Mass Spectrometry companies are 10x Genomics, Dovetail Genomics, S2 Genomics Inc, NanoString Technologies Inc, and Seven Bridges Genomics. To gain a competitive advantage in the industry, these market players are investing in partnerships, mergers and acquisitions, and expansion.
Some of the recent developments of key Spatial Mass Spectrometry providers are as follows:
Similarly, recent developments related to companies Spatial Mass Spectrometry services have been tracked by the team at Future Market Insights, which are available in the full report.
| Attributes | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America; Europe; Asia Pacific; Middle East & Africa; Latin America |
| Key Countries Covered | United States, UK, China, South Korea, Japan |
| Key Market Segments Covered | Technology, Product Type, Workflow, Sample Type |
| Key Companies Profiled | 10x Genomics; Dovetail Genomics; S2 Genomics Inc; NanoString Technologies Inc; Seven Bridges Genomics; PerkinElmer, Inc.; Bio-Techne; Danaher Corporation; IonPath, Inc.; Millennium Science Pty Ltd.; Akoya Biosciences, Ltd.; Fluidigm Corporation; Diagenode Diagnostics; Biognosys AG; Rebus Biosystems; Ultivue, Inc.; Vizgen Corp.; BioSpyder Technologies; Bruker; Brooks Automation, Inc. |
| Pricing | Available upon Request |
The global Spatial Mass Spectrometry Market is worth more than US$ 224.1 Mn at present.
Value of Spatial Mass Spectrometry Market are projected to increase at a CAGR of around 15.3% during 2022 – 2032.
Value of Spatial Mass Spectrometry Market increased at a CAGR of around 12.7% during 2017 – 2021.
The emergence of Spatial Mass Spectrometry analysis as a cancer diagnostic tool and the arrival of the fourth generation of sequencing are some of the key trends in Spatial Mass Spectrometry market.
The market for Spatial Mass Spectrometry Market in US is projected to expand at a CAGR of around 14.8% during 2022 – 2032.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 4. Global Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Technology 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032 5.3.1. Spatial Transcriptomics 5.3.1.1. Sequencing-based Methods 5.3.1.2. IHC 5.3.1.3. Microscopy-based RNA Imaging Techniques 5.3.2. Spatial Genomics 5.3.2.1. FISH 5.3.2.2. Microscopy-based Live DNA Imaging 5.3.2.3. Genome Perturbation Tools 5.3.2.4. Massively-parallel Sequencing 5.3.2.5. Other Spatial Genomics 5.3.2.6. Centrifugation Techniques 5.3.3. Spatial Proteomics 5.3.3.1. Imaging Techniques 5.3.3.2. Mass Spectrometry 5.3.3.3. Immunofluorescence Techniques 5.3.3.4. Centrifugation Techniques 5.3.3.5. Other Spatial Proteomics 5.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021 5.5. Absolute $ Opportunity Analysis By Technology, 2022-2032 6. Global Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 6.3.1. Instruments 6.3.2. Consumables 6.3.3. Software 6.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 6.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 7. Global Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Workflow 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By Workflow, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Workflow, 2022-2032 7.3.1. Sample Preparation 7.3.2. Instrumental Analysis 7.3.3. Data Analysis 7.4. Y-o-Y Growth Trend Analysis By Workflow, 2017-2021 7.5. Absolute $ Opportunity Analysis By Workflow, 2022-2032 8. Global Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Sample Type 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) Analysis By Sample Type, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Sample Type, 2022-2032 8.3.1. FFPE 8.3.2. Fresh Frozen 8.4. Y-o-Y Growth Trend Analysis By Sample Type, 2017-2021 8.5. Absolute $ Opportunity Analysis By Sample Type, 2022-2032 9. Global Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Technology 10.2.3. By Product Type 10.2.4. By Workflow 10.2.5. By Sample Type 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Technology 10.3.3. By Product Type 10.3.4. By Workflow 10.3.5. By Sample Type 10.4. Key Takeaways 11. Latin America Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Technology 11.2.3. By Product Type 11.2.4. By Workflow 11.2.5. By Sample Type 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Technology 11.3.3. By Product Type 11.3.4. By Workflow 11.3.5. By Sample Type 11.4. Key Takeaways 12. Europe Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. Italy 12.2.1.3. France 12.2.1.4. U.K. 12.2.1.5. Spain 12.2.1.6. Russia 12.2.1.7. BENELUX 12.2.1.8. Rest of Europe 12.2.2. By Technology 12.2.3. By Product Type 12.2.4. By Workflow 12.2.5. By Sample Type 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Technology 12.3.3. By Product Type 12.3.4. By Workflow 12.3.5. By Sample Type 12.4. Key Takeaways 13. Asia Pacific Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.1.4. India 13.2.1.5. Rest of Asia Pacific 13.2.2. By Technology 13.2.3. By Product Type 13.2.4. By Workflow 13.2.5. By Sample Type 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Technology 13.3.3. By Product Type 13.3.4. By Workflow 13.3.5. By Sample Type 13.4. Key Takeaways 14. MEA Spatial Mass Spectrometry Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC 14.2.1.2. Rest of MEA 14.2.2. By Technology 14.2.3. By Product Type 14.2.4. By Workflow 14.2.5. By Sample Type 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Technology 14.3.3. By Product Type 14.3.4. By Workflow 14.3.5. By Sample Type 14.4. Key Takeaways 15. Key Countries Spatial Mass Spectrometry Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Technology 15.1.2.2. By Product Type 15.1.2.3. By Workflow 15.1.2.4. By Sample Type 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Technology 15.2.2.2. By Product Type 15.2.2.3. By Workflow 15.2.2.4. By Sample Type 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Technology 15.3.2.2. By Product Type 15.3.2.3. By Workflow 15.3.2.4. By Sample Type 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Technology 15.4.2.2. By Product Type 15.4.2.3. By Workflow 15.4.2.4. By Sample Type 15.5. Argentina 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Technology 15.5.2.2. By Product Type 15.5.2.3. By Workflow 15.5.2.4. By Sample Type 15.6. Germany 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Technology 15.6.2.2. By Product Type 15.6.2.3. By Workflow 15.6.2.4. By Sample Type 15.7. Italy 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Technology 15.7.2.2. By Product Type 15.7.2.3. By Workflow 15.7.2.4. By Sample Type 15.8. France 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Technology 15.8.2.2. By Product Type 15.8.2.3. By Workflow 15.8.2.4. By Sample Type 15.9. U.K. 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Technology 15.9.2.2. By Product Type 15.9.2.3. By Workflow 15.9.2.4. By Sample Type 15.10. Spain 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Technology 15.10.2.2. By Product Type 15.10.2.3. By Workflow 15.10.2.4. By Sample Type 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Technology 15.11.2.2. By Product Type 15.11.2.3. By Workflow 15.11.2.4. By Sample Type 15.12. BENELUX 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Technology 15.12.2.2. By Product Type 15.12.2.3. By Workflow 15.12.2.4. By Sample Type 15.13. China 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Technology 15.13.2.2. By Product Type 15.13.2.3. By Workflow 15.13.2.4. By Sample Type 15.14. Japan 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Technology 15.14.2.2. By Product Type 15.14.2.3. By Workflow 15.14.2.4. By Sample Type 15.15. South Korea 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Technology 15.15.2.2. By Product Type 15.15.2.3. By Workflow 15.15.2.4. By Sample Type 15.16. India 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Technology 15.16.2.2. By Product Type 15.16.2.3. By Workflow 15.16.2.4. By Sample Type 15.17. GCC Countries 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Technology 15.17.2.2. By Product Type 15.17.2.3. By Workflow 15.17.2.4. By Sample Type 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Technology 16.3.3. By Product Type 16.3.4. By Workflow 16.3.5. By Sample Type 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. 10x Genomics 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segment 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Dovetail Genomics 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segment 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. S2 Genomics 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segment 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. NanoString Technologies, Inc. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segment 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Seven Bridges Genomics 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segment 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. PerkinElmer, Inc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segment 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Bio-Techne 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segment 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Danaher Corporation 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segment 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. IonPath, Inc. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segment 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Millenium Science Pty Ltd. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segment 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Akoya Biosciences, Ltd. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segment 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. Fluidigm Corporation 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segment 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.13. Diagenode Diagnostics 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segment 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.14. Biognosys AG 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segment 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 17.1.15. Rebus Biosystems 17.1.15.1. Overview 17.1.15.2. Product Portfolio 17.1.15.3. Profitability by Market Segment 17.1.15.4. Sales Footprint 17.1.15.5. Strategy Overview 17.1.15.5.1. Marketing Strategy 17.1.16. Ultivue, Inc. 17.1.16.1. Overview 17.1.16.2. Product Portfolio 17.1.16.3. Profitability by Market Segment 17.1.16.4. Sales Footprint 17.1.16.5. Strategy Overview 17.1.16.5.1. Marketing Strategy 17.1.17. Vizgen Corp. 17.1.17.1. Overview 17.1.17.2. Product Portfolio 17.1.17.3. Profitability by Market Segment 17.1.17.4. Sales Footprint 17.1.17.5. Strategy Overview 17.1.17.5.1. Marketing Strategy 17.1.18. BioSpyder Technologies 17.1.18.1. Overview 17.1.18.2. Product Portfolio 17.1.18.3. Profitability by Market Segment 17.1.18.4. Sales Footprint 17.1.18.5. Strategy Overview 17.1.18.5.1. Marketing Strategy 17.1.19. Bruker 17.1.19.1. Overview 17.1.19.2. Product Portfolio 17.1.19.3. Profitability by Market Segment 17.1.19.4. Sales Footprint 17.1.19.5. Strategy Overview 17.1.19.5.1. Marketing Strategy 17.1.20. Brooks Automation, Inc. 17.1.20.1. Overview 17.1.20.2. Product Portfolio 17.1.20.3. Profitability by Market Segment 17.1.20.4. Sales Footprint 17.1.20.5. Strategy Overview 17.1.20.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Spatial Mass Spectrometry Market
